- No authoritative public source confirms DCReport’s claim of a $34B New York Fed cash infusion to specific Wall Street banks on Dec. 28, 2025.
- Verified New York Fed data show large year-end usage of the collateralized Standing Repo Facility, including $25.95B on Dec. 29 and $74.6B on Dec. 31.
- Reports that the Fed removed a $500B daily cap apply to the SRF broadly, not to uncollateralized or bespoke “emergency cash infusions.”
- The dispute largely hinges on whether DCReport is conflating routine repo liquidity operations with bailout-style interventions.
Read More
The DCReport article claims that on December 28, 2025 at 5 PM, the New York Fed granted a $34 billion cash infusion to one or more Wall Street banks, following a recent removal of caps on emergency lender support. However, no federal agency or wire service has confirmed this specific transaction, timing, or the lifting of caps in those terms.
Authoritative data from Reuters and Investing.com confirms that on December 29, banks borrowed $25.95 billion via the SRF—a significant figure but different in date and scale than the DCReport narrative.
The largest confirmed repo activity was $74.6 billion borrowed through the SRF on December 31st, using Treasury and mortgage-backed securities as collateral. Viewers viewing that data should note it’s tied to routine facility operations during year-end pressures, not disclosed as unilateral bank rescues.
The DCReport’s claim that caps on “emergency cash infusions” have been quietly removed remains unsupported in publicly disclosed Federal Reserve or New York Fed materials. In fact, reports show that in late 2025, the Fed removed a $500 billion daily cap on SRF operations, which is a much different construct than a bespoke discretionary „cash infusion” window to individual banks.
Strategic implications hinge on how much stress is being buffered through transparent, collateralized repo tools versus opaque interventions. If true, undisclosed large transfers to individual banks would raise questions about counterparty risk, disclosure, and moral hazard. The lack of confirmation suggests either DCReport’s sourcing is weak or that financial markets are misinterpreting standard operations.
Open questions include: whether this $34 billion motion actually occurred but is not listed in SRF reports; which institutions would have been involved; whether there are other emergency or lesser-known lending tools now being used; and whether recent precious metals volatility has stimulated specific margin-call borrowing demand.
Supporting Notes
- On December 29, 2025, eligible financial firms borrowed $25.95 billion using the SRF, per New York Fed data reported by Reuters.
- On December 31, 2025, SRF usage spiked to $74.6 billion, split between $31.5 billion collateralized by Treasury securities and $43.1 billion by mortgage-backed securities.
- The Fed removed a $500 billion daily cap on SRF operations in late 2025; this is a system-wide constraint, not a targeted “cap on emergency cash infusions” to select banks.
- Bank reserves have fallen to around $2.8 trillion, their lowest in over four years, suggesting tightening liquidity conditions.
- DCReport also claims that there were virtually no large cash infusions from the New York Fed between mid-2020 and late 2025 until Halloween, when a $51 billion operation was alleged.
- No public source confirms DCReport’s precise timing (December 28 5 PM) or beneficiary banks of a $34 billion infusion.